APP and Alzheimer disease: Many transgenic flies of AD models overexpressing Aβ peptides have shown significantly disrupted sleep–wake patterns including increased time awake and decreased sleep, including in transgenic APP and presenilin 1 (APP/PS1) mouse (Kent et al. 2018).